System Transmission

Top Signal

100#1 JOB

Activity

2170Ripe

+926 today

System

Livenow

Terminal Asset View

stockNASDAQ

MCRB

$8.63-4.64%

Seres Therapeutics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

31Overripe

Live Analysis Active

Company Mission

This company creates microbiome-based therapies to treat serious gut infections like C. difficile. Doctors and hospitals use these treatments for patients who don't respond to standard antibiotics. It makes money by selling these drugs and partnering with healthcare providers.

MCR

Industry Context

This company operates in the biotechnology sector, focusing on innovative treatments for gut-related diseases. It competes with larger pharmaceutical firms by targeting niche areas with high unmet medical needs. The industry is driven by research breakthroughs and regulatory approvals, making it both high-risk and high-reward.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

81Matrix

Market Momentum

34.6— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-4.64%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing MCRB across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 12:31 AM UTC

As-of As of 2026-03-16T00:16:16.725Z UTC (~15m delay).

Develops microbiome-based therapies for serious gut infections, generating revenue through drug sales and partnerships with healthcare providers.

Weekly volatility is tightening near , a classic setup for a larger move as price compresses. Watch for a breakout above or below $8.50.

Volume spiked 3x at $1, indicating potential buyer interest because such surges often precede significant price shifts. Monitor if volume stays above average.

Biotech sector momentum is driving strength, with price holding above $8.50, signaling resilience in a volatile industry. Watch for industry trends like FDA approvals.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...